Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by francoiscnon Mar 14, 2018 7:42am
295 Views
Post# 27711483

My few on the next few weeks

My few on the next few weeksThe way I see it is for the next few weeks until FDA approval (whether early or not) we'll be in one of these scenarios, which make PLI "safer" now than it has been in the past :

1. We're range bound between 145-155 and then jump 30-40c on approval to ~1.90 and maybe continue the few days after to around $2

2. Bulls finally show up an anticipation of approval and we start creeping up to maybe 160-170 and approval adds another 30-40c to around $2 and then it continues a bit from there.

3. Shorts show up in the next few days and try to bring it back down but probably wont be able much further than 135 as it has been recently tested and rejected and bulls will probably see this as prices to average down for the upcoming catalyst and then we jump back 30-40c on approval to around $1.75s which is still higher than current sp.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse